title: Wild-type and IL10-null mice have differential colonic epithelial gene expression responses to dietary supplementation with synbiotic Bifidobacterium animalis subspecies lactis and inulin.
abstract: Prebiotic plus probiotic (synbiotic) supplementations promote fermentation and have shown anti-inflammatory activity in colonic epithelium. However, in many instances, patients with inflammatory bowel disease (IBD) have demonstrated adverse effects after prebiotic supplementation at a dose well tolerated by normal individuals. To test the hypothesis that the host inflammation affects the colonic epithelial response to increased fermentation, the gene expression of colonic epithelium was analyzed. In a 1-way experimental design to test the effect of supplements in wild-type mice using the standard diet formulated by the American Institute of Nutrition (AIN-93G) as the control diet, fermentable fiber inulin (5%) in the absence or presence of the probiotic Bifidobacterium animalis subspecies lactis (Bb12) (10(8) CFU/kg diet) showed limited effects on gene expression as determined by whole-genome microarray. Bb12 supplementation alone was known not to increase fermentation and here instead significantly upregulated genes in nucleic acid metabolic processes. The effects of the synbiotic diet were then determined in mice exposed to LPS-induced inflammation in a 2-way experimental design testing the effect of diet and LPS. The microarray and quantitative reverse transcription-polymerase chain reaction analyses on the wild-type mice revealed that LPS-induced changes in the colonic epithelium were 4- to 10-fold less in the synbiotic diet group compared with the control diet group. Unlike the wild-type mice, anti-inflammatory cytokine interleukin 10 (IL10)-null mice (susceptible to IBD) given the synbiotic diet, compared with those given the control diet, had 3- to 40-fold increased expression of inflammation-related genes such as Cxcl1 (chemokine C-X-C motif ligand 1) and S100a9 (S100 calcium binding protein A9) in the absence and presence of LPS exposure. These contrasting intestinal epithelial responses to increased fermentation in wild-type and IL10-null mice are similar to the difference between healthy human individuals and those with IBD, suggesting that the host disease/genetic background should be considered before prebiotic/probiotic supplementation.
authors.affiliation: Departments ofExercise and Nutrition Sciences.
authors.forename: Shiu-Ming
authors.initials: SM
authors.lastname: Kuo
authors.forename: Wan-Chun
authors.initials: WC
authors.lastname: Chan
authors.forename: Zihua
authors.initials: Z
authors.lastname: Hu
mesh_terms: D000818:Animals; D001644:Bifidobacterium; D003106:Colon / Q000378:metabolism; D004032:Diet; D004848:Epithelium / Q000378:metabolism; D015870:Gene Expression; D005838:Genotype; D007249:Inflammation / Q000139:chemically induced / Q000628:therapy; D015212:Inflammatory Bowel Diseases / Q000628:therapy; D016753:Interleukin-10 / Q000097:blood / Q000235:genetics; D007444:Inulin / Q000008:administration & dosage* / Q000378:metabolism; D008070:Lipopolysaccharides / Q000009:adverse effects; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D046228:Microarray Analysis; D056692:Prebiotics; D019936:Probiotics / Q000008:administration & dosage*; D012337:RNA, Ribosomal, 18S / Q000235:genetics; D058616:Synbiotics; D014409:Tumor Necrosis Factor-alpha / Q000097:blood
chemical_list: D008070:Lipopolysaccharides; D056692:Prebiotics; D012337:RNA, Ribosomal, 18S; D014409:Tumor Necrosis Factor-alpha; D016753:Interleukin-10; D007444:Inulin